RIO DE JANEIRO, BRAZIL - The consortium of the U.S. pharmaceutical company Pfizer and the German laboratory BioNTech announced Thursday (26) an agreement with the Brazilian multinational Eurofarma for the local production of its Covid-19 immunizer and its distribution in Latin America.
"Eurofarma will carry out manufacturing activities within the global Covid-19 vaccine supply chain and production network that Pfizer and BioNTech have, which now extends to 4 continents and will include 20 manufacturing units," the Brazilian pharmaceutical company said in a statement.
The agreement provides for "technical transfer, local development, and installation of equipment", actions that "will . . .